Global Healthcare Leaders Stress on Multi-stakeholder Engagement and AI-based Technology for a Healthy Future Indian Generation

– Wellness Centres integral to Fit India Movement and Preventive Healthcare strategies to tackle Diabetes & Anemia at the womb level – Bengaluru-based ARTIST has been involved in the training programme of maternal healthcare and non-communicable diseases VARANASI, India, Feb.…

Here’s why you shouldn’t spend long hours in office

According to a recent study, people who spend longer than usual hours at the workplace are more susceptible to the onset of hypertension. A considerable proportion of such individuals may also suffer a hidden form of hypertension, also known as masked hypertension, which as the name suggests may go undetected in clinical settings.

Long working hours may lead to high blood pressure, says study

Long working hours in the office can potentially trigger high blood pressure in overworked employees, according to a Canadian study published in American Heart Association’s journal ‘Hypertension’.

Legumes-rich diet lowers cardiovascular disease risk, improves heart health

A diet rich in beans, lentils, peas and other legumes lessens the risk of cardiovascular, coronary heart disease and high blood pressure, stated a new study. Published in the journal Advances in Nutrition, researchers in this study reviewed prospective cohort studies that assessed consumption of legumes on the risk for cardiometabolic diseases and related markers.

Artificial Sweeteners, an Alternative to the Sumptuous Silent Killer – Sugar

The Debate Continues, Says HEAL Foundation NEW DELHI, Nov. 14, 2019 /PRNewswire/ — India has the highest number of adults with type 2 Diabetes across the world. The International Diabetes Federation estimates that there were 72 million cases of diabetes in…

European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma

Not intended for US, Canada and UK-based media  — EU approval based on JAVELIN Renal 101 trial results demonstrating significant improvement in progression-free survival with BAVENCIO in combination with axitinib compared with sunitinib — Combination regimen approved across all IMDC…

Nobel Prize Recipient, Louis Ignarro, on Scientific Committee of “Fondazione Internazionale Menarini”

FLORENCE, Italy, Oct. 24, 2019 /PRNewswire/ — His discoveries have changed the lives of millions of people. Thanks to his insight, he has won the world’s most prestigious scientific honour. Today, his valuable experience will contribute towards bolstering the mission…

New Research on Climate Change and the Brain, the Relationship Between Stroke and Dementia, Advances in Epilepsy and MS Among the Brain Health Initiatives Unveiled at 24th World Congress of Neurology

LONDON, Oct. 21, 2019 /PRNewswire/ — Promising scientific research on the impact of climate change on brain health, advancements in epilepsy and multiple sclerosis, the relationship between stroke and dementia, new data on gene therapies and neurogenerative diseases and developments…

Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis

MUMBAI, Oct. 11, 2019 /PRNewswire/ — Johnson & Johnson today announced it has committed to ensuring more than $500 million is dedicated to world class research & development and delivery programs over the next four years to accelerate global efforts…

Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer

The PRIMA study, presented in a Presidential Symposium at the 2019 European Society for Medical Oncology congress and simultaneously published in The New England Journal of Medicine, demonstrates that niraparib treatment resulted in a 38% reduction in the risk of…